Bolt Biotherapeutics, Inc.
BOLT
$3.68
-$0.18-4.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.39% | -41.06% | -41.88% | -40.69% | -52.82% |
| Total Receivables | -87.00% | -97.89% | -16.48% | 123.06% | -50.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.61% | 21.50% | -5.38% | -7.88% | -1.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -74.49% | -74.49% | -55.30% | -1.01% | -- |
| Total Current Assets | -46.36% | -39.42% | -40.45% | -37.69% | -49.97% |
|
|
|||||
| Total Current Assets | -46.36% | -39.42% | -40.45% | -37.69% | -49.97% |
| Net Property, Plant & Equipment | -20.64% | -15.51% | -17.75% | 5.22% | 2.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.08% | 59.88% | 60.69% | -8.52% | -41.97% |
| Total Assets | -46.56% | -44.06% | -43.04% | -40.50% | -39.20% |
|
|
|||||
| Total Accounts Payable | -53.13% | 13.17% | -4.25% | 2.43% | -29.50% |
| Total Accrued Expenses | -42.76% | -71.92% | -64.37% | -63.19% | -27.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.79% | 23.17% | 25.54% | -4.39% | -14.56% |
| Total Finance Division Other Current Liabilities | -66.80% | -73.48% | -68.22% | -42.98% | -48.19% |
| Total Other Current Liabilities | -66.80% | -73.48% | -68.22% | -42.98% | -48.19% |
| Total Current Liabilities | -36.09% | -45.86% | -46.80% | -44.89% | -31.23% |
|
|
|||||
| Total Current Liabilities | -36.09% | -45.86% | -46.80% | -44.89% | -31.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.29% | -13.25% | -12.31% | 36.06% | 36.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -52.11% | -52.53% | -53.70% | -45.77% | -39.76% |
| Total Liabilities | -24.42% | -27.78% | -28.73% | -11.66% | -4.33% |
|
|
|||||
| Common Stock & APIC | 0.53% | 0.54% | 0.58% | 0.61% | 0.76% |
| Retained Earnings | -6.43% | -6.75% | -7.81% | -10.37% | -12.80% |
| Treasury Stock & Other | -633.33% | -127.50% | -121.65% | -104.88% | 86.36% |
| Total Common Equity | -67.46% | -57.65% | -53.66% | -55.43% | -54.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -67.46% | -57.65% | -53.66% | -55.43% | -54.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -67.46% | -57.65% | -53.66% | -55.43% | -54.76% |
|
|
|||||